Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
This report contains market size and forecasts of Varicella Vaccine in global, including the following market information:
Global Varicella Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Varicella Vaccine Market Sales, 2017-2022, 2023-2028, (M Doses)
Global top five Varicella Vaccine companies in 2021 (%)
The global Varicella Vaccine market was valued at 4294.8 million in 2021 and is projected to reach US$ 7108.9 million by 2028, at a CAGR of 7.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Varicella Vaccine include Merck, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross and Biken, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Varicella Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Varicella Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Doses)
Global Varicella Vaccine Market Segment Percentages, by Type, 2021 (%)
Injection
Freeze-Dried Powder
Global Varicella Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Doses)
Global Varicella Vaccine Market Segment Percentages, by Application, 2021 (%)
Kids Injection
Adults Injection
Global Varicella Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Doses)
Global Varicella Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Varicella Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Varicella Vaccine revenues share in global market, 2021 (%)
Key companies Varicella Vaccine sales in global market, 2017-2022 (Estimated), (M Doses)
Key companies Varicella Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken